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Transcription factor complexes have varied effects
on cell fate and behavior, but how this diversifica-
tion of function occurs is largely unknown. The Nodal
signaling pathway hasmany biological functions that
all converge on the transcription factors Smad2/3.
Smad2/3 has many cofactors, and alternative usage
of these may provide a mechanism for modulating
Smad2/3 function. Here, we investigate how pertur-
bation of the cofactor E2a affects global patterns of
Smad2/3 binding andgene expression during gastru-
lation. We find that E2a regulates early development
in two ways. E2a changes the position of Smad2/3
binding at the Nodal inhibitor lefty, resulting in direct
repression of lefty that is critical for mesendoderm
specification. Separately, E2a is necessary to drive
transcription of Smad2/3 target genes, including crit-
ical regulators of dorsal cell fate andmorphogenesis.
Overall, wefind that E2a functionsasbotha transcrip-
tional repressor and activator to precisely regulate
Nodal signaling.
INTRODUCTION
During embryogenesis, transcription factor complexes can
mediate many aspects of cell fate specification by regulating
diverse sets of transcriptional targets at different points in time
or space. While this scenario is well appreciated, there remains
little mechanistic insight into how it is achieved. What variables
direct the choice of where a transcription factor will bind and
whether the outcome of binding has an activating, repressive,
or neutral effect on the expression of the target? Several models
have demonstrated that transcription factors can have variable
associations with other proteins and with chromatin, resulting
in different effects on gene transcription. A particularly well-stud-
ied example is the Brg1 and Brm family of ATPase complexes
(BAF complexes), in which alternative use of BAF subunits signif-
icantly alters the transcriptional regulatory activity of the com-
plex during the progression from embryonic stem cells (esBAFs)
to neural progenitors (npBAFs) and neurons (nBAFs) (Yoo and
Crabtree, 2009). BAF complexes have over 10,000 targets inDevelopthe mouse genome (Ho et al., 2009) and can repress or activate
neuronal gene transcription through differential interaction with
coactivators or corepressors. Other models of transcription fac-
tor target choice include the Drosophilamesoderm factor Twist,
which binds different targets at different developmental stages
(Zinzen et al., 2009); the Nodal signaling transcription factor
Smad2/3, which associates with different targets in human
endoderm versus stem cells (Kim et al., 2011); and the basic-he-
lix-loop-helix (bHLH) factor E2a, which has different transcrip-
tional targets in progressive stages of B cell development (Lin
et al., 2010). However, the mechanisms that govern the switch
between activation and repression of target genes, or the effects
of removing or adding a subunit on the global behavior of a tran-
scription factor complex as a whole, remain poorly understood.
There remains little to no insight into how subtle changes in
the interacting components of complexes cause widespread
transcriptional differences and drastic cellular consequences in
embryos in vivo.
In early vertebrate embryogenesis, the Nodal signaling
pathway, acting through the transcription factors Smad2/
Smad3, is critical for many aspects of early development and
cellular differentiation, including deeply conserved roles in
mesendoderm development and left/right axis specification (re-
viewed in Schier, 2003; Shen, 2007). How Nodal signaling drives
many aspects of embryonic development by using a simple
downstream network focused primarily on a single transcription
factor complex, Smad2/3, remains unclear. Transcriptional
regulation of Smad2/3 targets is finely balanced by autoregula-
tion: Nodal ligands are, themselves, transcriptional targets of
Smad2/3, as is the Nodal inhibitor lefty (Cheng et al., 2000; Bran-
ford and Yost, 2002; Meno et al., 1999). This sets up a precise
gradient of Nodal signaling activity, but how this gradient is inter-
preted into different transcriptional outcomes at the level of
Smad2/3 binding is not understood. Possible mechanismsmight
include Smad2/3 binding to different target genes at different
signal strengths, stronger or more stable accumulation of
Smad2/3 at target sites, or association with different cofactors.
Several cofactors have been discovered to interact with
Smad2/3 in order to drive different functional aspects of Nodal
signaling, including FoxH1/Fast1 (Labbe´ et al., 1998),Mixer (Ger-
main et al., 2000), Eomes (Slagle et al., 2011; Teo et al., 2011), and
the bHLHproteins E2a andHeb (Yoon et al., 2011). It is not known
whether any of these factors can directly influence genomic
target choice by Smad2/3 or how the gain or loss of these factors
affects the transcriptional behavior of the Smad2/3 complex.mental Cell 32, 345–357, February 9, 2015 ª2015 Elsevier Inc. 345
To understand how transcriptional cofactors regulate Smad2/
3 binding and gene transcription in the developing embryo, we
investigated the requirement for the bHLH transcription factor
E2a in Nodal signaling. E2a is a required cofactor for Nodal
signaling in mesendoderm specification, as embryos depleted
for E2a fail to form mesoderm, have reduced endoderm, and
fail to gastrulate (Yoon et al., 2011). Insights fromE2a’s role in he-
matopoiesis point to several potential models for how E2a might
modulate Smad2/3 binding. In B-cell development, E2a can act
as either a transcriptional activator or a repressor through its
association with coactivators and corepressors or by forming
homodimers and heterodimers in association with other class I
or class II bHLH proteins, which can be repressors or activators
(reviewed in Kee, 2009). E2a can also associate with transcrip-
tional coactivators such as p300, CBP, and TAF4 through one
of two activation domains (ADs) (Bayly et al., 2004; Bradney
et al., 2003; Chen et al., 2013) or with the ETO/myeloid transloca-
tion gene (MTG) class of corepressors through the AD2 and
downstream ETO-interacting sequence domains (Gow et al.,
2014; Guo et al., 2009; Zhang et al., 2004). E2a can, therefore,
have potentially widespread effects on transcriptional regulation
across the genome, although the effects of E2a loss of function
on global transcription patterns have not been investigated.
In this study, we asked what effect perturbation of E2a has on
the behavior and function of the Smad2/3 multiprotein complex
in the in vivo embryo. We identify two critical roles for E2a. First,
E2a is essential for proper positioning of Smad2/3 at the lefty
genomic locus. This direct interaction is mechanistically respon-
sible for repressing lefty transcription. In the absence of E2a, lefty
is dramatically upregulated, leading to failure of mesendoderm
fate specification. Second, a set of genes require E2a not for
Smad2/3 localization but for transcriptional activation, leading
to a failure of gastrulation morphogenesis in E2a-depleted
embryos. E2a can directly target these genes for activation by
occupying the same regulatory regions as Smad2/3. Overall,
we demonstrate that the Smad2/3 transcriptional cofactor,
E2a, plays two critical roles in the regulation of early develop-
ment by repressing transcription of the Nodal inhibitor lefty and
by activating transcription of axial mesoderm genes. Perturba-
tion of these roles has dramatic consequences for cell fate spec-
ification and morphogenesis.
RESULTS
To identify how E2a affects the association of Smad2/3 with
chromatin and transcription of Nodal target genes, we depleted
E2A in Xenopus embryos and examined them using chro-
matin immunoprecipitation sequencing (ChIP-seq) and RNA
sequencing (RNA-seq) (Wills et al., 2014). Specifically, we in-
jected two-cell-stage X. tropicalis embryos with an E2a morpho-
lino (MO) and harvested these embryos, as well as uninjected
sibling controls, at early gastrula (stage 10.5). We then conduct-
ed ChIP-seq using anti-Smad2/3 antibodies and RNA-seq with
the same cohorts of embryos. Each experiment was performed
in duplicate except ChIP-seq of Smad2/3 in E2a-depleted em-
bryos, which was performed in triplicate. For ChIP-seq, each
library was made using 1,000 embryos, according to published
methods (Wills et al., 2014), and our existing control Smad2/3
library data were used as one replicate (Gupta et al., 2014). For346 Developmental Cell 32, 345–357, February 9, 2015 ª2015 ElseviRNA-seq, each library was made using 20 mg of total starting
RNA, according to published methods (Tan et al., 2013).
We then determined if Smad2/3 requires E2a to associate with
chromatin across the genome.We examined ChIP-seq data sets
using Bowtie software to align ChIP-seq reads to the X. tropicalis
xenTro2 (version 4.1) genome and used MACS2 software to call
peaks. This analysis revealed 1,027 regions bound by Smad2/3
in control embryos and 1,671 in E2a-depleted embryos. We next
used BedTools software to compare the genomic coordinates of
Smad2/3-associated regions in control embryos with those in
E2a-depleted embryos.We classified these regions into four cat-
egories: (1) regions that maintain Smad2/3; (2) regions where the
genomic position of Smad2/3 is shifted slightly; (3) regions that
lose all Smad2/3 binding; and (4) regions that gain Smad2/3
binding. Forty-eight percent (495/1,027) of the Smad2/3 binding
falls into category 1, meaning that these regions are not affected
by E2A depletion (Figure 1A). Conversely, this also means that
52% (532/1,027) of Smad2/3-binding regions are mislocalized
when E2A is depleted. Overall, this indicates that E2a is not
required for basic association of Smad2/3 with chromatin at
gastrulation but does direct Smad2/3 positioning at many loci,
while other loci are correctly targeted independently of E2a.
Next, we sought to examine the genes associated with the four
categories of E2A-affected genomic regions. We used HOMER
software to associate Smad2/3-bound regions to their nearest
neighboring genes. We found 341 genes associated with stable
Smad2/3 binding (category 1), 192 genes associated with a
shift in Smad2/3 (category 2); 277 genes associated with total
Smad2/3 loss (category3), and571genes that gain anassociation
with Smad2/3 (category 4) (Figure 1B; Table S1 available online).
We performed gene ontology analysis using DAVID clustering
(Huang et al., 2009a, 2009b) to identify whether any of these cat-
egories of geneswas enriched for particular biological processes.
We found that, while all categories showed enrichment for
‘‘transcription regulation,’’ only genes within category 1 (stable
binding)were significantly enriched for developmental processes,
including anterior/posterior patterning (enrichment score, 5.47;
p = 6.8 3 106), developmental protein (enrichment score, 5.4;
p = 1.1 3 1013), GATA-type transcription factor (p = 3.8 3
103),mesodermdevelopment (p=4.43102), andWntsignaling
(enrichment score, 3.76; p = 2.23 106) (Figure 1C). This category
of genes also contains many well-known Nodal target genes that
are critical for early development, including cer1, eomes, gsc,
xbra/t, sox17b, pitx2, not, nodal1, and vegt, as well as receptors
and ligands for Wnt and FGF signaling. Overall, this suggests
that developmental genes maintain association with a stable
Smad2/3 element that is not affected by E2A depletion.
Our results suggest that E2A isnot required for theplacementof
Smad2/3 at many developmental loci. Therefore, we surmised
that E2a might instead act to enable transcription of these genes
in response toSmad2/3binding. To this end,wefirst identified the
effect of E2a depletion on gene expression across the genome.
Using the RNA-seq data sets obtained from E2A-depleted and
control embryos, after performing normalization of fragments
per kilobase of transcript permillionmapped reads (FPKM) to ac-
count for variations in transcript length, we found that only 197
genes are significantly downregulated in E2a-depleted embryos,
while 3,957 genes were significantly upregulated (Table S2).
Therefore, we infer that, genome-wide, E2a is more frequentlyer Inc.
Figure 1. E2a Is Required for Subsets of Smad2/3 Binding and for Global Patterns of Smad2/3 Target Gene Expression
(A) Smad2/3 targets 1,027 distinct genomic regions in control stage 10.5 embryos (yellow) and 1,671 regions in E2a-depleted embryos (blue). Four hundred
ninety-five regions are targeted in both conditions.
(B) Categories of Smad2/3 binding behavior in E2a-depleted embryos (blue) relative to controls (yellow).
(C) DAVID clustering analysis shows enrichment for developmental (dev) terms in all Smad2/3-associated genes and for genes that have stable Smad2/3 binding
when E2a is depleted (red box in B) but not other subcategories of Smad2/3 binding. Ant/Post, anterior/posterior.
(D) Genes that retain Smad2/3 binding at the same genomic coordinates in E2a-depleted embryos (red box in B) are more likely to be downregulated by 2-fold or
more in E2a-depleted embryos.
(E and F) Significant overlap exists between genes that are Smad2/3 targets and genes that are downregulated in E2a-depleted embryos. Smad2/3 targets in
which binding is at the same genomic position in control and E2a-depleted embryos are more likely to be downregulated in E2a-depleted embryos. These genes
maintain enrichment for DAVID terms associated with early development.
See also Tables S1 and S2.
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Table 1. List of All Genes inwhich Smad2/3Binding IsMaintained
at the Same Position in Control and E2a-Depleted Embryos and
that Are Significantly Downregulated in E2a-Depleted Embryos
Gene Name
Expression (Mean
E2a/Mean Ctrl) Function Type
mespb 0.008080432 transcription factor
cer1 0.010092776 signaling molecule
pcdh8.2 0.010779418 cytoskeleton/transport
t (xbra) 0.027910383 transcription factor
frzb 0.033973786 transmembrane receptor
gatm 0.058238471 other/unknown
lhx1 0.061176421 transcription factor
hhex 0.075792824 transcription factor
gs17 0.082842955 other/unknown
foxa4 0.105938633 transcription factor
gsc 0.111275047 transcription factor
gata4 0.112514562 transcription factor
slc38a3 0.135985709 cytoskeleton/transport
rspo2 0.155234594 signaling molecule
nudt22 0.173302279 other/unknown
foxc2 0.183713832 transcription factor
foxd3 0.195581307 transcription factor
epha4 0.244381447 transmembrane receptor
otx2 0.265712657 transcription factor
gata5 0.279417037 transcription factor
ngfr 0.28420678 transmembrane receptor
ror2 0.298173092 signaling molecule
nr6a1 0.305514516 transcription factor
eomes 0.327671011 transcription factor
cox7b 0.381125295 other/unknown
wnt5b 0.389808629 signaling molecule
zic3 0.436294732 transcription factor
hpdl 0.439688059 other/unknown
efna1 0.459150746 signaling molecule
ventx1.1 0.487513979 transcription factor
snai1 0.506217054 transcription factor
vegt 0.514365172 transcription factor
fgf8 0.53150366 signaling molecule
pkdcc.1 0.534870368 other/unknown
gata6 0.54800291 transcription factor
tsg101 0.550753067 cytoskeleton/transport
crx 0.564716113 transcription factor
map2k6 0.586210367 intracellular signaling
wnt11 0.590079259 signaling molecule
MGC76328 0.593841587 other/unknown
znf703 0.597459616 transcription factor
cdc42ep4 0.642916664 cytoskeleton/transport
lpar2 0.644983354 transmembrane receptor
stx6 0.64601592 cytoskeleton/transport
LOC496805 0.671603875 unknown/other
fzd8 0.695453455 transmembrane receptor
348 Developmental Cell 32, 345–357, February 9, 2015 ª2015 Elseviassociated with transcriptional repression, not activation. How-
ever, the 197 genes downregulated in E2a-depleted embryos
are heavily enriched for Smad2/3 target genes (73/197; 3.41-
fold enrichment relative to whole gene set, p = 1.09 3 1027).
This is particularly notable for genes in category 1, where
Smad2/3 remains stable (46/197, 6.38-fold enrichment) (Figures
1D–1F). Furthermore, if we examine the 46 downregulated genes
that are associatedwith a stableSmad2/3 region, these represent
many of the most critical and well-known Nodal target genes in
early development (Table 1), and these maintain strong enrich-
ment for DAVID terms associated with early development and
patterning (Figure 1F). We were surprised to observe that these
genescouldbestronglydownregulatedat the transcriptional level
while maintaining Smad2/3 binding. This suggests that E2a is
essential for transcription of these genes and that Smad2/3
binding alone is not sufficient to drive transcription. Overall, we
conclude that E2a functions to repress gene transcription of
many genes genome-wide but that its role in gene activation pre-
dominates for early developmental Nodal target genes. Critically,
while E2a is not required for Smad2/3 localization to these target
genes, it is essential for their transcriptional activation.
E2a Directly Represses Transcription of the Nodal
Inhibitor lefty
As E2a mostly serves to inhibit gene expression within the Xeno-
pus embryo, we investigated whether its role as an activator for
early developmental Nodal target genes might be indirect as a
consequence of the ectopic upregulation of a Nodal antagonist.
To this end, we examined whether any known inhibitors of Nodal
signaling were highly expressed in E2a-depleted embryos.
Notably, we find that the well-studied Nodal inhibitor Lefty is
highly upregulated in E2a-depleted embryos (8.97-fold increase).
We confirmed the expression of lefty by qRT-PCR in both control
and E2a-depleted embryos (Figure 2A). To examine the spatial ef-
fects of this upregulation, we performed in situ hybridization for
lefty inE2a-depletedandE2a-overexpressingembryos.We found
that, at stage 10.5, E2a-depleted embryos have stronger expres-
sion of lefty throughout the marginal zone (15/18 embryos with
upregulated expression) compared to stage-matched controls
(Figure 2B). Conversely, in embryos injectedwith E2amRNA, lefty
expression is inhibited (13/18; Figure 2B). Thus, we foundmultiple
lines of evidence that expression of lefty is repressed by E2a. This
suggests that the downregulation of 46 Smad2/3 target genes
observed in our RNA-seq data could potentially arise indirectly
through the upregulation of Lefty in E2a-depleted embryos.
We next investigated whether the misexpression of lefty in
response to E2a depletion may be caused by changes in
Smad2/3 occupancy at lefty regulatory regions. We found two
regions near the lefty locus that contain densely clustered
consensus sequences for Foxh1, Smad, Ebox, and SCA motifs
(Yoon et al., 2011) (Figure 2C).We found that, in control embryos,
Smad2/3 binding is usually strongly enriched at the first of these
two clusters (‘‘region 1’’ in Figure 2). In E2a-depleted embryos,
Smad2/3 is no longer enriched at region 1 but instead becomes
more strongly enriched at region 2 (Figure 2D). We conclude that
E2a regulates expression and Smad2/3 positioning at the Nodal
target gene and inhibitor lefty, suggesting that E2a could serve
to displace Smad2/3 from region 1 to region 2, resulting in higher
levels of lefty transcription.er Inc.
Figure 2. E2a Regulates Samd2/3 Posi-
tioning at lefty and Represses lefty Tran-
scription
(A) qRT-PCR showing upregulation of lefty in E2a-
depleted embryos and downregulation of gsc and
xbra. odc is shown as a loading control (Ctrl). Error
bars represent SDs for three biological replicates.
(B) In situ hybridization for lefty expression at stage
10 in control, E2a-depleted, and e2a mRNA-
injected embryos (red, lacZ lineage tracer).
(C) Distribution of key transcription factor binding
sites near the lefty locus. There are two regions of
observed Smad2/3 binding in control embryos,
schematized in blue.
(D) In E2a-depleted embryos, Smad2/3 binding
at region 1 is reduced, while binding at region 2 is
increased. Fold enrichment over input is shown
along the y axis.
(E) Embryos were injected at the two-cell stage
with mE2a-GFP- and RFP-tagged histone H2b
mRNA and monitored for fluorescence at stage
10.5.
(F) ChIP-qRT-PCR using anti-GFP antibodies in
stage 10.5 embryos following mE2a-GFP injection
at the two-cell stage. The y axis represents fold
enrichment over a negative (neg) control region
near the lefty locus. Error bars represent SDs of
two to three biological replicates.
See also Figure S1.As our results strongly implicate E2a as a transcriptional
repressor of lefty, we used a functional tagged E2A construct
to examine whether E2a directly associates with these putative
lefty regulatory regions. We generated an E2a-GFP fusion
construct, in which GFP is fused in frame to the coding region
of mouse E2a (mE2a-GFP). We confirmed the functionality of
this construct in several ways. First, injection of 500 pg mE2a-
GFP mRNA results in GFP-positive embryos with fluorescence
restricted to the nuclei of injected cells, as expected for a tran-
scription factor (Figure 2E). Western blots using embryo lysatesDevelopmental Cell 32, 345–357from mE2a-GFP-injected embryos react
with an anti-GFP antibody at the ex-
pected size for this fusion, and mE2a-
GFP can rescue the formation of bottle
cells in E2a-depleted embryos: the darkly
pigmented, apically constricted cells that
form the leading edge of the blastopore
(Figures S1A and S1B). As the mE2a-
GFP construct functions similarly to
wild-type E2A, we used this mE2a-GFP
fusion to test whether E2a was enriched
at either region 1 or region 2 within the
lefty locus. We injected 1,000 embryos
at the two-cell stage with 500 pg per
cell of mE2a-GFP mRNA, raised these
embryos to stage 10.5, and performed
ChIP using an anti-GFP antibody, fol-
lowed by qRT-PCR using primers spe-
cific for region 1, region 2, or a negative
control region (Figure 2C). We found
that, while there is little to no E2a associ-ation with region 1, there is very strong enrichment of E2a asso-
ciation at region 2 (Figure 2F). Overall, this suggests that E2a
binds directly to region 2, inhibiting the association of Smad2/3
and subsequently downregulating lefty transcription.
E2a Is Required in Mesendoderm Cells for Blastopore
Formation
As Lefty is an important regulator of Nodal signaling in mes-
endoderm and dorsal midline cells, we next examined whether
E2A was specifically required for the formation of these cells., February 9, 2015 ª2015 Elsevier Inc. 349
Figure 3. Lefty Is Downstream of E2a in Mesoderm Induction
(A) Embryoswere injectedwith E2aMO in specific blatomeres as follows: All, both blastomeres at the two-cell stage (n = 72); Dorsal, two dorsal blastomeres at the
four-cell stage (n = 51); Ventral, both ventral blastomeres at the four-cell stage (n = 63); Animal, four animal blastomeres at the eight-cell stage (n = 9).
(B) Embryos were injected in both blastomeres at the two-cell stage with e2a MO and/or at the animal pole at the four-cell stage with xnr1 mRNA. Animal caps
were harvested at stage 8 and cultured to stage 10. qRT-PCRs were normalized to whole embryo expression and to odc expression. Error bars represent SDs for
three biological replicates.
(C–J) E2a-depleted embryos have reduced expression of gsc (E) and xbra (F) compared with uninjected control embryos (C and D). By contrast, Lefty-depleted
embryos show increased expression of gsc (G) and xbra (H). Embryos injected with both E2a and Lefty MOs have moderate expression of gsc (I) and xbra (J).
See also Figure S2.Therefore, we targeted E2a MOs to dorsal, ventral, animal, or
vegetal blastomeres andanalyzed thephenotypic consequences
of E2a knockdown in these regions. We found that when E2A is
depleted from dorsal-vegetal cells, the blastopore does not
form (78%) (Figure 3A) or is incomplete (18%). Blastopore forma-
tion is inhibited or absent in fewer embryoswhere ventral-vegetal
blastomeres (prospective ventral mesoderm and endoderm) are
injected with E2a MO (20% absent, 26% incomplete), and it is
normal in most embryos where only animal blastomeres (pro-
spective ectoderm) are injected with E2a MO (92% normal) (Fig-
ure 3A). Thus, E2a is primarily required in regions of the embryo350 Developmental Cell 32, 345–357, February 9, 2015 ª2015 Elsevithat have a high level of Nodal signaling; particularly, those cells
that will contribute to dorsal mesendoderm.
E2A Opposes Nodal Activation of lefty
As E2a is required in regions of the embryo with high levels of
endogenous Nodal signaling, we next determined whether E2a
requires Nodal signaling to regulate lefty. To this end, we exam-
ined E2a depletion in isolated ectodermal explants, which
contain no Nodal signaling. We injected E2a MO into the animal
pole of the two-cell-stage embryo, isolated animal ectoderm ex-
plants at stage 8, cultured these to stage 10.5, and analyzed leftyer Inc.
expression by qRT-PCR. In contrast to E2a-depleted whole
embryos, lefty is not upregulated in E2a-depleted ectoderm ex-
plants (Figure 3B), suggesting that E2a repression of lefty does
not occur in the absence of Nodal signaling.
We then determined if E2a depletion leads to increased
expression of lefty in response to Nodal signaling. To this end,
we performed a double injection experiment within the prospec-
tive ectoderm, in which we first depleted E2a by injecting MOs at
the two-cell stage and then induced Nodal expression by inject-
ing mRNA for the Nodal ligand xnr1 at the four-cell stage. We
then isolated and cultured ectoderm explants from xnr1-injected
or E2a MO/xnr1 double-injected embryos and assayed expres-
sion of mesoderm genes and lefty by qRT-PCR. As expected,
lefty is induced by overexpression of xnr1 (Figure 3B). In embryos
injectedwith both xnr1 and E2aMO, lefty expression in ectoderm
is significantly increased. Thus, E2a depletion enhances lefty
expression when Nodal (xnr1) is present, suggesting that Lefty
is downstream of both Nodal and E2a.
Lefty Is Epistatic to E2a Depletion in Mesoderm
Induction
To explicitly test if Lefty is downstream of E2a, we examined
whether depletion of Lefty is epistatic to depletion of E2a. We
injected embryos at the two-cell stage with E2a MO, Lefty MO,
or both MOs; raised them to stage 10.5; and analyzed their
morphology and gene expression. In E2a-depleted embryos,
expression of the dorsal mesoderm gene gsc is reduced, as is
expression of the panmesoderm marker xbra (Figures 3E and
3F). By contrast, in Lefty-depleted embryos, the domain of gsc
expression is expanded ventrally, and the xbra expression
domain is expanded animally (Figures 3G and 3H). Surprisingly,
when both MOs were coinjected at the two-cell stage, we
observed recovery of expression for xbra (24/28) and gsc (19/
24) (Figures 3I and 3J). Although the expression of xbra and
gsc was restored in E2a/Lefty double-knockdown embryos,
gastrulation behaviors were still abnormal, with impaired bottle
cell formation and failure of blastopore closure (data not shown).
These data suggest that a substantial reason for the loss of
expression of mesoderm genes in E2a-depleted embryos results
from upregulation of lefty, which can be rescued by a compen-
sating depletion of lefty. However, these results further suggest
that the blastopore formation defects may arise from a lefty-
independent role of E2a.
E2a Is Required for Dorsal MesodermGene Activation in
Ectoderm Explants
We next asked whether E2a has a role in gene activation, inde-
pendent from its role in repression of lefty transcription. While
E2a is well known as a transcriptional activator in hematopoiesis
(Bradney et al., 2003; Kee, 2009; Chen et al., 2013), two lines of
evidence prompted us to investigate whether it was also acting
as an activator in the early embryo. First, manywell-knownNodal
target genes are downregulated in the absence of E2a but retain
Smad2/3 binding (Figure 1; Table 1). This is not explained well by
upregulation of Lefty alone. Lefty acts to sequester Nodal ligands
and to antagonize EGF-CFC coreceptors (Chen and Shen, 2004;
Cheng et al., 2000, 2004). Both thesemechanisms result in an in-
hibition of Smad2 phosphorylation and translocation to the nu-
cleus; therefore, wewould expect to see loss of Smad2/3 bindingDevelopconcurrently with downregulation of transcription of these genes.
The presence of Smad2/3 in E2a-depleted embryos, coupled
with a strong transcriptional downregulation of these genes,
suggests that E2a might also be necessary as a transcriptional
activator. Second, while downregulation of Lefty is sufficient
to rescue expression of xbra and gsc, it is not sufficient for rescue
of gastrulation morphogenesis. Therefore, we investigated
whether E2a might function to activate dorsal mesoderm gene
expression and promote gastrulation morphogenesis through
an additional mechanism independent from lefty repression.
We first asked if E2a is necessary or sufficient for gene activa-
tion in ectoderm explants, which do not express lefty. To this
end, we performed qRT-PCR for expression of representative
genes from Table 1 in whole embryos, E2a-depleted embryos,
control ectoderm explants, and ectoderm explants injected
with e2a mRNA (Figure 4A). This confirmed that E2a is required
for expression of xbra, eomes, and epha4 in whole embryos
but revealed that e2a overexpression is not sufficient to induce
expression of these genes in ectoderm. As our previous work
has shown that E2a binds with Smad at gene regulatory regions
in human embryonic stem cell (hESC)-derived endoderm, we hy-
pothesized that E2a might be required downstream of Nodal to
activate gene expression. Therefore, we tested whether eomes,
xbra, or epha4 gene expression in ectoderm depends on both
Nodal signaling and E2a. We injected xnr1 mRNA, in the pres-
ence or absence of E2a MO, and quantified expression of
xbra, eomes, and epha4. All three genes are robustly activated
in the ectoderm by xnr1 injection, but this activation is signifi-
cantly reduced in ectoderm that is also depleted of E2a (Figures
4A and S3). This demonstrated that E2a is necessary but not suf-
ficient for Nodal-dependent transcriptional activation of these
genes. However, as lefty is also expressed in response to xnr1
(Figure 3), this experiment did not fully clarify whether this
requirement for E2a was as a direct activator.
E2a Directly Targets Regulatory Regions of Dorsal
Mesoderm and Morphogenesis Genes
We next tested explicitly whether dorsal mesoderm genes
and morphogenesis genes are targeted directly by E2a. To this
end, we first identified putative regulatory regions in genes that
require E2a for their expression but that have intact Smad2/3
binding in the absence of E2a (Table 1). We examined the
sequence of regions that are bound by Smad2/3 in both the
presence and absence of E2a to identify putative E2a binding
sites in these regions (SCA motifs; Yoon et al., 2011). We find
that SCA motifs frequently occur within 5 kb of these regions.
To test whether E2a binds these regions, we performed ChIP-
qRT-PCR using mE2a-GFP at putative regulatory regions for
three genes that require E2a for transcription: eomes, xbra,
and epha4 (Figure 4B). We find that mE2a-GFP is significantly
enriched at these regulatory regions relative to ChIP performed
with GFP alone (Figure 4C). This suggests that these three
genes, and likely others from Table 1, are direct targets of E2a
for transcriptional activation.
E2a-EnR Fusion Proteins Repress Axial Mesoderm
Development
We next asked whether E2a’s function as a transcriptional acti-
vator is required for normal development. We have shown thatmental Cell 32, 345–357, February 9, 2015 ª2015 Elsevier Inc. 351
Figure 4. E2a Is Required for Dorsal Mesoderm Gene Expression and Binds Directly to These Target Genes
(A) qRT-PCRs comparing expression of xbra, eomes, and epha4 in whole stage 10.5 control or e2a-depleted embryos and in ectoderm explants. Expression
levels are normalized to odc and to control ectoderm explants. Error bars represent the SD for three biological replicates, with two technical replicates per
biological replicate. Note that although error bars for eomes expression are large, reflecting biological variation between groups of explants, eomes expression
was lower in E2a MO + Xnr1 ectoderm than in Xnr1 ectoderm in every biological replicate.
(B) Regulatory regions for eomes, epha4, and xbrawere identified fromChIP-seq analysis in Figure 1, and regulatory regions that are occupied by Smad2/3 in both
control and e2a-depleted embryos were analyzed for E2a occupancy. Primers, Smad, FoxH1, and E2a (SCA) binding sites as well as the positions of Smad2/3
peaks are shown as in Figure 2.
(C) ChIP-qRT-PCR for mE2a-GFP shows significant enrichment at regulatory regions for eomes, xbra, and epha4. qRT-PCRs are normalized to expression in
embryos injected with GFP alone, and to expression of an off-peak primer. Error bars represent SDs of two to three biological replicates.
See also Figure S3.E2a directly targets the dorsal mesoderm genes xbra and eomes
and the morphogenesis gene epha4 and that E2a is required for
Nodal-dependent activation of these genes, but it was not yet
clear which early developmental functions were driven by this
role of E2a, as opposed to its role in Lefty repression. We were
specifically interested in whether E2a acts as an activator in
gastrulation morphogenesis, as this process is poorly rescued
by inhibition of Lefty in E2a-depleted embryos. Notably, several
of the 46 Smad2/3 target genes downregulated in E2a-depleted
embryos (Table 1) are regulators of cytoskeletal changes and
cell movements, suggesting that these genes might mediate
bottle cell formation and gastrulation movements as targets of
E2a activation (epha4, as well as cdc42ep4, lpar2, efna1, lpar2,
map2k6, and pcdh8.2). Overexpression of e2a mRNA has mini-352 Developmental Cell 32, 345–357, February 9, 2015 ª2015 Elsevimal effects on gastrulation, apart from local inhibition of lefty
expression (Figure 2; data not shown). Therefore, to separate
E2a’s activator and repressor functions, we made an obligate
repressor by fusing E2a to the repressor domain of Engrailed.
We then injected 250 pg of E2a-EnR or 20 ng of E2A MO in
both blastomeres at the two-cell stage. We harvested these
embryos and stage matched controls at stage 11 and examined
their morphology and gene expression. We find that E2a-EnR-
injected embryos have delayed blastopore closure (Figure 5A)
and, like E2a-depleted embryos, have reduced expression of
xbra in injected cells. In contrast to E2a-depleted embryos,
E2a-EnR-injected cells have reduced lefty expression, demon-
strating that E2a-EnR represses lefty. Later in development, em-
bryos injected with E2a-EnR have defects in dorsal and axialer Inc.
mesoderm development, with truncated tails and spina bifida.
E2a-EnR-injected embryos also showed reduced expression of
several genes we had found to be downregulated in E2a mor-
phants by RNA-seq, including the muscle markers myoD and
myf5 and the notochord marker foxA1 (Figure 5B). Ventral meso-
derm development appeared to be unaffected, as E2a-EnR-
injected embryos have normal expression of the heart marker
nkx2.5. These phenotypic effects are less dramatic than the
failure of blastopore formation and loss of mesendoderm spec-
ification seen in E2a morphants. We have shown that proper
gastrulation morphogenesis and specification of axial meso-
derm are inhibited by E2a when acting as a repressor and reveal
that these functions rely instead on E2a acting as an activator. It
is interesting that the E2a-EnR repressor fusion closely pheno-
copies the effects of an Xbra-EnR repressor fusion protein,
which also causes a shortened axis and reduced axial meso-
derm (Conlon et al., 1996; Kitaguchi et al., 2002). These effects
are consistent with our observation that E2a directly targets
both early axial mesoderm genes such as eomes and xbra,
and early morphogenesis genes such as epha4 (Evren et al.,
2014; Park et al., 2011). It also supports observations from our
RNA-seq analysis that E2a is normally required for expression
of many axial mesoderm genes, including xbra, myod, myf5,
and foxa1, and that E2a-EnR conversely targets these genes
for repression. Therefore, we conclude that E2a must usually
act to activate expression of genes associated with gastrulation
morphogenesis and axial mesoderm development as well as to
repress lefty expression.
E2a Functions as Both an Activator and a Repressor to
Drive Gastrulation
As we have revealed that E2A functions as both an activator
and repressor, we next sought to examine whether these two ac-
tivities could combine to phenocopy the severe phenotype of
E2a-depleted embryos, in which the blastopore fails to form.
To this end, we injected lefty mRNA alone, e2a-enR alone, lefty
and e2a-enR together, or E2a MO into X. tropicalis embryos
and examined the resulting effects on bottle cell formation. We
chose 5 pg of lefty mRNA as equivalent to the level of lefty
expression in E2a-depleted embryos (Figure S2) and 250 pg of
e2a-enR mRNA as a dose that robustly represses mesoderm
development. We find that this dose of lefty alone causes incom-
plete inhibition of bottle cell formation and that E2a-EnR, while
causing a delay in gastrulation, does not affect bottle cell forma-
tion (Figure 5C). Surprisingly, we found that lefty and e2a-enR
synergize to repress all bottle cell formation, strongly suggesting
that each of these contributes partially to E2a’s role in bottle cell
formation (27/29 embryos with no bottle cells) (Figure 5C). We
conclude that E2a has two functions—lefty repression and dor-
sal gene activation—and that inhibiting both functions is neces-
sary for full recapitulation of the E2a loss-of-function phenotype,
as inhibition of either function alone leads tomoremodest effects
on gastrulation.
DISCUSSION
Multiprotein transcriptional complexes can have diverse func-
tions depending on their conformation and genomic position.
The Smad2/3 complex mediates a wide variety of cellular andDevelopdevelopmental events, including mesendoderm development,
left/right axis specification, cell division, metastasis, and plurip-
otency (Schier, 2009; Shen, 2007). Smad2/3 associates with
many potential cofactors, but the effect that these cofactors
have on diversifying the roles of Smad2/3 are largely unknown,
especially in the context of the in vivo embryo. Here, we found
evidence that a Smad2/3 transcriptional cofactor, E2a, regu-
lates early development in two ways: through transcriptional
repression of the Nodal inhibitor lefty and through transcrip-
tional activation of dorsal mesoderm and morphogenesis
genes.
E2a plays an essential role in mesendoderm development by
repressing transcription of the Nodal inhibitor Lefty. As a conse-
quence, in E2a-depleted embryos, Lefty is dramatically upregu-
lated, leading to a failure of mesendoderm cell fate specification.
We find that E2a achieves this role by directing the position of
Smad2/3 at the lefty genomic locus. We find that Smad2/3 can
occupy one of two positions at the lefty locus, and in the
absence of E2a, Smad2/3 is displaced from its usual position
to one nearer the lefty transcriptional start site. As a result, lefty
transcription is dramatically upregulated (Figure 6A). This upre-
gulation has strongest effect in dorsal-vegetal cells and requires
endogenous Nodal signals, demonstrating that the effect of E2a
is specifically through the Nodal signaling pathway, through the
positioning of Smad2/3. We favor a mechanism by which E2a
excludes Smad2/3 from associating with region 2 of lefty,
so that it fails to associate with transcriptional coactivators.
This may be a more general mechanism at other sites where
Smad2/3 positioning is gained or shifted in the absence of
E2a. In hESCs, pluripotency is maintained by the repressive
activity of a complex made up of Taz/Yap/Tead4, Oct4, and
Smad2/3 at mesendoderm gene enhancers, which is relieved
and switched to activation in the presence of Activin (Beyer
et al., 2013). Our data demonstrate that E2a plays a similar
role in governing the switch between repression and activation
at some enhancers in the early embryo. In the absence of E2a,
many genes (>3,000) are upregulated, suggesting that E2a
acts broadly as a transcriptional repressor, and many genes
gain Smad2/3 binding (571) or have shifted Smad2/3 binding
(192). At some loci, E2amay also act more directly as a repressor
by recruiting corepressors, as it does in association with ETO/
MTG corepressors in hematopoiesis (Gow et al., 2014; Guo
et al., 2009; Zhang et al., 2004). However, Lefty is, by far, the
most critical target of E2a repression for early cell fate specifica-
tion, as downregulation of Lefty is sufficient to rescue expression
of mesoderm genes in E2a-depleted embryos. An intriguing re-
maining question is why E2a competes with Smad2/3 binding
at this locus, given that E2a and Smad2/3 are able to directly
associate and co-occupy transcriptional regulatory regions
at other genes (Figure 4; Yoon et al., 2011). One potential
explanation is that E2a and Smadmay have context-specific as-
sociations with other bHLH proteins, such as HEB, which may
influence either Smad binding choice or coactivator recruitment.
While our earlier work suggests that HEB is not required for early
embryonic development, it is expressed throughout the meso-
derm at gastrulation (Yoon et al., 2011) and may play a role
redundantly with E2a.
E2a is also required at 46 critical early developmental Smad2/
3 target genes, not for Smad2/3 positioning, but for theirmental Cell 32, 345–357, February 9, 2015 ª2015 Elsevier Inc. 353
Figure 5. E2a Fused to the Engrailed Repressor Domain Causes Mild Blastopore Formation Defects and Loss of Axial Mesoderm and
Synergizes with Low Doses of lefty mRNA
(A) Effects of E2a-EnR injection (both cells at the two-cell stage) at stage 11. Embryos injected with E2a-EnR have delayed blastopore closure relative to
uninjected control embryos but far better blastopore formation than E2a morphants. Stage 10.5 E2a-EnR embryos express more xbra than E2a morphants but
less than control embryos. E2a-EnR-injected embryos express less lefty than E2a morphants.
(B) Effects of E2a-EnR injection (both cells at the two-cell stage) at stage 30. E2a-EnR-injected embryos show reduced expression of muscle markers (myoD,
myf5) and notochord markers (shh, foxA2) but normal expression of the heart marker nkx2.5.
(C) E2a-Enr and 5 pg of lefty mRNA each cause only modest effects on blastopore closure, but embryos injected with both mRNAs show a failure of bottle cell
formation similar to E2a morphants. Arrowhead indicates bottle cells.transcriptional activation (Table 1). This role is distinct from
repression of Lefty. These genes include many well-known tran-
scription factors regulating early mesendoderm development,
as well as several regulators of cell shape changes and move-
ments that act in gastrulation morphogenesis. This is substanti-
ated by ChIP of E2a, which demonstrates that E2a binds directly
to the regulatory regions of several of these genes including
eomes, xbra, and epha4. At these loci, Smad2/3 is positioned
normally, but transcription is inhibited, demonstrating that E2a
is needed more directly for their activation. In hESCs, the local-
ization of E2a to mesendoderm genes is strongly dependent on
Nodal signaling, suggesting that in this activator capacity, E2a
requires Smad2/3 to properly target mesendoderm genes
(Yoon et al., 2011). The activity of E2a as a transcriptional acti-
vator has dramatic consequences for gastrulation morphogen-
esis. Notably, epha4 has recently been shown to regulate dorsal354 Developmental Cell 32, 345–357, February 9, 2015 ª2015 Elsevimesoderm involution through xbra (Evren et al., 2014), and so
the regulation of these two genes by E2a explains why the
loss of E2a has dramatic consequences on gastrulation move-
ments. When E2a is forced to lose its activator role by becoming
a repressor, gastrulation movements and axial mesoderm for-
mation are perturbed. For these genes, we hypothesize that
E2a is critical for coupling Smad2/3 binding to transcriptional
activation (Figure 6B). In other cell types, E2a is essential for
recruitment of transcriptional coactivators like CPB and p300
(Bayly et al., 2004; Bradney et al., 2003), and we consider it likely
that, in the embryo, E2a also acts as a bridge between Smad2/3
and these coactivators. Some genes, like xbra, may be regu-
lated by E2a both through its repression of Lefty and through
direct transcriptional activation. Thus, E2a represents another
layer in the finely balanced regulation of Nodal signaling and
its targets in the early embryo.er Inc.
Figure 6. Model of Smad2/3 and E2a Interactions in Transcriptional
Regulation
(A) At the lefty locus. In control embryos, Smad2/3 normally occupies region 1,
while E2a normally occupies region 2. Transcription of lefty is weak. In the
absence of E2a, Smad2/3 moves to preferentially occupy region 2, and tran-
scription of lefty is upregulated.
(B) At dorsal mesoderm loci. In control embryos, Smad2/3 occupancy at en-
hancers is coupled by E2a to coactivators, and transcription of the target gene
(epha4 is shown as an example) is robust. In the absence of E2a, the coupling
of Smad2/3 to transcriptional coactivators is lost, and transcription of the
target gene is reduced.Overall, we demonstrate that E2a has critical functions, both as
a repressor and activator, in the localization and function of the
Smad2/3 transcriptional complex. These findings highlight that
perturbation of a single component of a transcriptional complex
can have dramatic consequences for behavior of the complex
in vivo. TheSmad2/3 complex differentially regulatesmanygenes
at gastrulation, with different effects in distinct cell types. This
study reveals that E2astrongly influencesbothbinding site choice
of the Smad2/3 complex throughout the genome and the conse-
quences of Smad2/3 binding on gene expression. By preventing
strong transcription of lefty and by allowing transcriptional activa-
tion of other Nodal target genes, E2a has a profound effect on
many aspects of early development regulated byNodal signaling.
EXPERIMENTAL PROCEDURES
Xenopus tropicalis Embryo Culture
Xenopus tropicalis husbandry procedures were performed according to proto-
cols approved byNIH and the Stanford University Institutional Animal Care and
Use Committee. Embryos were generated by natural mating as described
elsewhere (Yoon et al., 2011; Khokha et al., 2002). Staging was assessed ac-
cording to Niewkoop and Faber (1994). For microsurgery details, see the Sup-
plemental Experimental Procedures.
RNA-Seq Library Preparation
Total RNA was isolated by collecting duplicate cohorts of 100 embryos
for control and E2a-depleted embryos. Twenty micrograms of starting
total RNA was used for each library. The Illumina HiSeq platform was
used for sequencing. Reads were aligned to the X. tropicalis 4.1 genome
version and corresponding annotation. FPKM normalization and downstreamDevelopdifferential expression analysis was carried out as described elsewhere (Tan
et al., 2013). See the Supplemental Experimental Procedures for additional
details.
ChIP-Seq Library Preparation
Duplicate cohorts of 200 control or E2a-depleted embryos were fixed for ChIP
as described elsewhere (Blythe et al., 2009; Wills et al., 2014). Immunoprecip-
itation was carried out using anti-Smad2/3 antibodies (Santa Cruz Biotech-
nology, sc-8332) or anti-GFP antibodies (Life Technologies #A11122, lot
1296649). Sequencing and analysis was carried out on the Illumina hi-Seq
platform as described elsewhere (Wills et al., 2014). In brief, libraries were
aligned to the X. tropicalis 4.1 genome version using bwa. Peaks were called
using MACS2. Peaks were assigned to the nearest neighboring genes using
HOMER, with the xentro2 annotation tool. Comparisons of peak positions
were carried out using BedTools. Analyses comparing genes implicated in
ChIP-seq and genes implicated in RNA-seq were conducted using in house
Perl scripts or Unix tools.
See Supplemental Experimental Procedures for ChIP-qRT-PCR primers.
Microinjection
MO oligonucleotide design and microinjection information is as follows:
E2A MO oligonucleotide sequence: TGTCATCCTCTGCTGTTGATTCATT
(Yoon et al., 2011); and
Lefty MO oligonucleotide sequence: CATGTGCTAGTGACACCCATC
TTGC.
mRNA Synthesis and Injection
Linearized plasmid DNA was transcribed with Sp6 polymerase, using an NTP
mix containing 50 methyl-G cap (mMESSAGE mMACHINE, Ambion). mRNA
was precipitated first with LiCl, then reprecipitated using ammonium acetate,
quantitated, resuspended, and stored at 80C. Injections were performed at
stages and with amounts specified in each experiment.
The following mRNA plasmids and amounts were used:
X. tropicalis E2a: IMAGE 7660124, 250 pg per blastomere;
Mouse E2a: IMAGE clone 2631291, 500 pg per blastomere;
E2a:GFP (clone details are discussed later), 250 pg per blastomere;
E2a:EnR (clone details are discussed later), 250 pg per blastomere; and
X. laevis Xnr1: 100 pg per embryo.Whole-Mount In Situ Hybridization
Embryos were developed to the desired stage and then fixed in MEMFA for
2–6 hr at room temperature or overnight at 4C. X. tropicalis multibasket
in situ hybridization protocols were followed as described in Khokha et al.
(2002). For plasmids used for in situ hybridization probes, see the Supple-
mental Experimental Procedures.
qRT-PCR
Total RNA was isolated from injected or uninjected embryos (three per
experiment) or animal caps (ten per experiment). RNA was treated with DNase
1 (Invitrogen, catalog #18068-015) and cDNA synthesized using SuperScript III
reverse transcriptase (Invitrogen). The qRT-PCR analysis was performed using
the BioRad SYBR Green labeling system, the BioRad iCycler PCR machine,
SYBR Green mix, and BioRad analysis software. For PCR details and primers,
see Supplemental Experimental Procedures.
E2a Fusion Protein Constructs
The mouse E2a-GFP fusion was made by fusing the carboxy terminus of
mouse E2a to the amino terminus of EGFP on a CS2 backbone. The
X. tropicalis E2a-EnR fusion was made by fusing the Engrailed repressor
domain to the carboxy terminus of X. tropicalis E2a on a pCMV Sport6 back-
bone. For details, see the Supplemental Experimental Procedures.
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